Get access

A literature review on flow-rate variability in neonatal IV therapy

Authors

  • Anne C. van der Eijk,

    Corresponding author
    1. Department of Neonatology, Erasmus MC – Sophia Children's Hospital;]?>, University Medical Centre Rotterdam;]?>, Rotterdam, the Netherlands
    • Department of BioMechanical Engineering, Faculty of Mechanical, Maritime & Materials Engineering, Delft University of Technology;]?>, Delft, the Netherlands
    Search for more papers by this author
  • Roland M.F.P.T. van Rens,

    1. Department of Neonatology, Erasmus MC – Sophia Children's Hospital;]?>, University Medical Centre Rotterdam;]?>, Rotterdam, the Netherlands
    Search for more papers by this author
  • Jenny Dankelman,

    1. Department of BioMechanical Engineering, Faculty of Mechanical, Maritime & Materials Engineering, Delft University of Technology;]?>, Delft, the Netherlands
    Search for more papers by this author
  • Bert J. Smit

    1. Patient Directorate Erasmus MC;]?>, University Medical Centre Rotterdam;]?>, Rotterdam, the Netherlands
    Search for more papers by this author

Correspondence

Anne C. van der Eijk, Department of BioMechanical Engineering, Faculty of Mechanical, Maritime & Materials Engineering, Delft University of Technology, Mekelweg 2, 2628CD Delft, The Netherlands

Email: a.c.vandereijk@tudelft.nl

Summary

Aim

To provide an overview of factors influencing the flow rate in intravenous (IV) therapy for newborns.

Methods

We conducted a review of the literature from 1980 to 2011 in PubMed and Web of Knowledge. Articles focusing on flow-rate variability and possible complications due to flow-rate variability were included.

Results

Forty-one articles were selected for this review. IV therapy in (preterm) neonates is prone to significant start-up delays and flow-rate variability. The sudden changes in the volume delivered to (preterm) neonates may have serious consequences. Low preprogrammed flow rates, total compliance, and volume of the IV administration set, the presence or absence of antisiphon valves or inline filters and the vertical displacement of syringe pumps all contribute to flow-rate variability in IV therapy for neonates.

Conclusions

Flow-rate variability in IV therapy and its clinical relevance are due to the preprogrammed flow rate, the hydrostatic pressure changes, the complete IV administration set compliance and the type of substances supplied to the patient. To improve IV therapy, the internal compliance of the complete IV administration set should be minimized and the highest possible preprogrammed flow rate should be used in combination with small syringes and low-resistance valves.

Ancillary